Literature DB >> 14632811

Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1-year local control.

J V Moore1, E Allan.   

Abstract

BACKGROUND: The regression of clinical basal cell carcinoma (BCC) after photodynamic therapy (PDT) is poorly understood, but is potentially important when, as is increasingly the case, a second treatment is contemplated. High-frequency pulsed ultrasound provides noninvasive information on skin and lesion thickness.
OBJECTIVES: To relate pulsed ultrasound measurements before and after PDT to the probability of local control of BCC by PDT.
METHODS: Skin thickness and lesion thickness were measured by 20-MHz pulsed ultrasound in 181 patients diagnosed as having BCC. Maximal lesion thickness was determined by repeatedly sampling the BCCs. Measurements were made immediately prior to PDT with aminolaevulinic acid plus 630 nm visible light, and then at 1, 6 and 12 months.
RESULTS: Skin thickness in individual patients did not vary with time in this study (mean +/- SD 2.3 +/- 0.6 mm; P = 0.8). In contrast, BCC mean +/- SD maximal thickness 4-6 weeks after PDT was significantly smaller than pretreatment (0.6 +/- 0.8 mm vs. 1.3 +/- 0.8 mm; P < 0.001). The overall probability of 1-year local control fell from 85% when only BCCs </= 1.5 mm thick were considered, to 75% when BCCs up to 3 mm were included.
CONCLUSIONS: Ultrasound measurement of maximal pretreatment BCC thickness strongly predicts the probability of local control, defined clinically, at 1 year after a single PDT treatment. The degree of regression at 4-6 weeks is additionally predictive.

Entities:  

Mesh:

Year:  2003        PMID: 14632811     DOI: 10.1111/j.1365-2133.2003.05558.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  Preoperative mapping of nonmelanoma skin cancer using spatial frequency domain and ultrasound imaging.

Authors:  Daniel J Rohrbach; Daniel Muffoletto; Jonathan Huihui; Rolf Saager; Kenneth Keymel; Anne Paquette; Janet Morgan; Nathalie Zeitouni; Ulas Sunar
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

2.  Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery.

Authors:  Anokhi Jambusaria-Pahlajani; Chrysalyne D Schmults; Christopher J Miller; Daniel Shin; Jennifer Williams; Shanu K Kurd; Joel M Gelfand
Journal:  Dermatol Surg       Date:  2008-11-19       Impact factor: 3.398

3.  Monitoring blood flow responses during topical ALA-PDT.

Authors:  Theresa L Becker; Anne D Paquette; Kenneth R Keymel; Barbara W Henderson; Ulas Sunar
Journal:  Biomed Opt Express       Date:  2010-12-15       Impact factor: 3.732

4.  Anatomical and molecular imaging of skin cancer.

Authors:  Hao Hong; Jiangtao Sun; Weibo Cai
Journal:  Clin Cosmet Investig Dermatol       Date:  2008-10-07

Review 5.  Ultrasound and Infrared-Based Imaging Modalities for Diagnosis and Management of Cutaneous Diseases.

Authors:  Sheliza Halani; F Stuart Foster; Maksym Breslavets; Neil H Shear
Journal:  Front Med (Lausanne)       Date:  2018-04-25

Review 6.  Basal cell carcinoma - diagnosis.

Authors:  Małgorzata Mackiewicz-Wysocka; Monika Bowszyc-Dmochowska; Daria Strzelecka-Węklar; Aleksandra Dańczak-Pazdrowska; Zygmunt Adamski
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07

7.  Short-term effects of vacuum massage on epidermal and dermal thickness and density in burn scars: an experimental study.

Authors:  Jill Meirte; Peter Moortgat; Mieke Anthonissen; Koen Maertens; Cynthia Lafaire; Lieve De Cuyper; Guy Hubens; Ulrike Van Daele
Journal:  Burns Trauma       Date:  2016-07-08

Review 8.  Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer.

Authors:  Scott C Hester; Maju Kuriakose; Christopher D Nguyen; Srivalleesha Mallidi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.